Epoprostenol Exposure During Pregnancy
Institutional policies restricting pregnant providers from caring for patients receiving inhaled epoprostenol exist across the nation based on little to no data to substantiate this practice. Over the last 2 decades, the use of inhaled pulmonary vasodilators has expanded in patients with cardiac and...
Main Authors: | Emily E. Naoum, MD, Carolyn LaVita, MHA, RRT, Natasha Lopez, PharmD, BCCCP, Alexa Nardone, PharmD, BCCCP, Marti D. Soffer, MD, MPH, Kenneth T. Shelton, MD |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer
2023-06-01
|
Series: | Critical Care Explorations |
Online Access: | http://journals.lww.com/10.1097/CCE.0000000000000928 |
Similar Items
-
Implementation and Impact of Critical Care Pharmacist Addition to a Telecritical Care Network
by: Rachel M. Belcher, PharmD, BCCCP, et al.
Published: (2023-01-01) -
Practices and Outcomes Associated With Sublingual Buprenorphine Use in a Critically Ill Population
by: Denis J. Vanini, PharmD, BCCCP, et al.
Published: (2024-03-01) -
Prevalence and Risk Factors for Iatrogenic Opioid Withdrawal in Medical Critical Care Patients
by: Marlena A. Fox, PharmD, BCPS, BCCCP, et al.
Published: (2023-05-01) -
Optimizing Pharmacist Team-Integration for ICU Patient Management: Rationale, Study Design, and Methods for a Multicentered Exploration of Pharmacist-to-Patient Ratio
by: Kelli Keats, PharmD, MPA, BCCCP, et al.
Published: (2023-09-01) -
Precipitated withdrawal with kratom use following naltrexone administration
by: Jarka Courtney PharmD, BCPS, BCPP, et al.
Published: (2023-06-01)